Gynecologic Cancer Research at a Crossroads
Journal Title: Gynecology and Obstetrics Research – Open Journal - Year 2014, Vol 1, Issue 1
Abstract
Gynecologic cancer research is currently at a crossroads. Recent changes in the NCI’s approach to clinical cancer research have resulted in a complex makeover of the federal clinical research community. This was prompted by perceived inefficiencies in the existing model, as well as the realities of stagnant (or declining) funding for the foreseeable future.
Authors and Affiliations
William Robinson
Keywords
Related Articles
- EP ID EP553423
- DOI 10.17140/GOROJ-1-e001
- Views 197
- Downloads 0
Case Report of Unusual Stromal Luteinization in High-Grade Papillary Serous Carcinoma of the Ovary
Stromal luteinization has been reported to be associated with benign and malignant epithelial ovarian tumors, predominantly mucinous and often endometrioid ovarian neoplasm. We report here an unusual case of marked ovari...
High-Throughput Next Generation Sequencing: Applications in Reproductive Diagnosis and Research
The genetic information contained within a cell is transferred through the process of transcription of genes within a genome to produce messenger RNAs (mRNAs) and translation of mRNAs to synthesize proteins. The central...
Bilateral Massive Hematoma of Bartholin Glands after Prolonged Labour: A Case Report
Background: The early postpartum hematoma represents a rare complication which can appear in the early post-partum period. Its formation and development is favoured by the hypervascularization of the genital area during...
Developmental Environmental Exposure Alters the Epigenetic Features of Myometrial Stem Cells
Uterine fibroids (UFs), are the most common pelvic tumors, occurring in 70-80% of all reproductive-aged women and are the leading indication for hysterectomy worldwide.1-3 Although UFs are benign tumors, they typically c...
Competing Endoscopic Surgeries in the Era of Assisted Reproductive Technologies: Evidence and Practice
Now-a-days the assisted reproductive technologies (ART) are progressing and advancing rapidly. Many reproductive medicine specialists do believe in ART to be the first choice for infertile women regardless of age related...